HEADER HYDROLASE 07-JUL-09 3I6M TITLE 3D STRUCTURE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED TITLE 2 WITH N-PIPERIDINOPROPYL-GALANTHAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACETYLCHOLINESTERASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 23-556; COMPND 5 SYNONYM: ACHE; COMPND 6 EC: 3.1.1.7 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TORPEDO CALIFORNICA; SOURCE 3 ORGANISM_COMMON: PACIFIC ELECTRIC RAY; SOURCE 4 ORGANISM_TAXID: 7787 KEYWDS SERINE HYDROLASE, CHOLINESTERASE, NEUROTRANSMITTER DEGRADATION, KEYWDS 2 ALZHEIMER'S DISEASE, BIS-FUNCTIONAL GALANTHAMINE DERIVATIVE, KEYWDS 3 ALTERNATIVE SPLICING, CELL JUNCTION, CELL MEMBRANE, DISULFIDE BOND, KEYWDS 4 GLYCOPROTEIN, GPI-ANCHOR, HYDROLASE, LIPOPROTEIN, MEMBRANE, SERINE KEYWDS 5 ESTERASE, SYNAPSE EXPDTA X-RAY DIFFRACTION AUTHOR D.LAMBA,C.BARTOLUCCI REVDAT 5 06-SEP-23 3I6M 1 REMARK HETSYN REVDAT 4 29-JUL-20 3I6M 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 01-NOV-17 3I6M 1 REMARK REVDAT 2 02-FEB-10 3I6M 1 JRNL REVDAT 1 12-JAN-10 3I6M 0 JRNL AUTH C.BARTOLUCCI,L.A.HALLER,U.JORDIS,G.FELS,D.LAMBA JRNL TITL PROBING TORPEDO CALIFORNICA ACETYLCHOLINESTERASE CATALYTIC JRNL TITL 2 GORGE WITH TWO NOVEL BIS-FUNCTIONAL GALANTHAMINE JRNL TITL 3 DERIVATIVES. JRNL REF J.MED.CHEM. V. 53 745 2010 JRNL REFN ISSN 0022-2623 JRNL PMID 20025280 JRNL DOI 10.1021/JM901296P REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.M.GREENBLATT,C.GUILLOU,D.GUENARD,A.ARGAMAN,S.BOTTI, REMARK 1 AUTH 2 B.BADET,C.THAL,I.SILMAN,J.L.SUSSMAN REMARK 1 TITL THE COMPLEX OF A BIVALENT DERIVATIVE OF GALANTHAMINE WITH REMARK 1 TITL 2 TORPEDO ACETYLCHOLINESTERASE DISPLAYS DRASTIC DEFORMATION OF REMARK 1 TITL 3 THE ACTIVE-SITE GORGE: IMPLICATIONS FOR STRUCTURE-BASED DRUG REMARK 1 TITL 4 DESIGN REMARK 1 REF J.AM.CHEM.SOC. V. 126 15405 2004 REMARK 1 REFN ISSN 0002-7863 REMARK 1 PMID 15563167 REMARK 1 DOI 10.1021/JA0466154 REMARK 1 REFERENCE 2 REMARK 1 AUTH H.M.GREENBLATT,G.KRYGER,T.LEWIS,I.SILMAN,J.L.SUSSMAN REMARK 1 TITL STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH REMARK 1 TITL 2 (-)-GALANTHAMINE AT 2.3A RESOLUTION REMARK 1 REF FEBS LETT. V. 463 321 1999 REMARK 1 REFN ISSN 0014-5793 REMARK 1 PMID 10606746 REMARK 1 DOI 10.1016/S0014-5793(99)01637-3 REMARK 1 REFERENCE 3 REMARK 1 AUTH C.BARTOLUCCI,E.PEROLA,C.PILGER,G.FELS,D.LAMBA REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF A COMPLEX OF GALANTHAMINE REMARK 1 TITL 2 (NIVALIN) WITH ACETYLCHOLINESTERASE FROM TORPEDO REMARK 1 TITL 3 CALIFORNICA: IMPLICATIONS FOR THE DESIGN OF NEW REMARK 1 TITL 4 ANTI-ALZHEIMER DRUGS REMARK 1 REF PROTEINS V. 42 182 2001 REMARK 1 REFN ISSN 0887-3585 REMARK 1 PMID 11119642 REMARK 1 DOI 10.1002/1097-0134 REMARK 1 REFERENCE 4 REMARK 1 AUTH C.PILGER,C.BARTOLUCCI,D.LAMBA,A.TROPSHA,G.FELS REMARK 1 TITL ACCURATE PREDICTION OF THE BOUND CONFORMATION OF REMARK 1 TITL 2 GALANTHAMINE IN THE ACTIVE SITE OF TORPEDO CALIFORNICA REMARK 1 TITL 3 ACETYLCHOLINESTERASE USING MOLECULAR DOCKING REMARK 1 REF J.MOL.GRAPH.MODEL. V. 19 288 2001 REMARK 1 REFN ISSN 1093-3263 REMARK 1 PMID 11449566 REMARK 1 DOI 10.1016/S1093-3263(00)00056-5 REMARK 1 REFERENCE 5 REMARK 1 AUTH E.LUTTMANN,E.LINNEMANN,G.FELS REMARK 1 TITL GALANTHAMINE AS BIS-FUNCTIONAL LIGAND FOR THE REMARK 1 TITL 2 ACETYLCHOLINESTERASE. REMARK 1 REF J.MOL.MODEL. V. 8 208 2002 REMARK 1 REFN ESSN 0948-5023 REMARK 1 PMID 12140604 REMARK 1 REFERENCE 6 REMARK 1 AUTH L.ALISARAIE,G.FELS REMARK 1 TITL A QXP-BASED MULTISTEP DOCKING PROCEDURE FOR ACCURATE REMARK 1 TITL 2 PREDICTION OF PROTEIN-LIGAND COMPLEXES REMARK 1 REF J.CHEM.INF.MODEL. V. 46 1174 2006 REMARK 1 REFN ISSN 1549-9596 REMARK 1 PMID 16711737 REMARK 1 DOI 10.1021/CI050343M REMARK 2 REMARK 2 RESOLUTION. 2.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1997132.140 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 46822 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4701 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.26 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.33 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 46.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3572 REMARK 3 BIN R VALUE (WORKING SET) : 0.2420 REMARK 3 BIN FREE R VALUE : 0.2710 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 397 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4263 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 71 REMARK 3 SOLVENT ATOMS : 398 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.30000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 8.30000 REMARK 3 B13 (A**2) : -16.60000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.21 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.28 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.020 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED INDIVIDUAL ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.733 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.525 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.789 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.908 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 62.80 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3I6M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JUL-09. REMARK 100 THE DEPOSITION ID IS D_1000054029. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-01 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ELETTRA REMARK 200 BEAMLINE : 5.2R REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : THREE-SEGMENT PT-COATED TOROIDAL REMARK 200 MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46878 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.260 REMARK 200 RESOLUTION RANGE LOW (A) : 19.820 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 9.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04700 REMARK 200 FOR THE DATA SET : 8.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.41800 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1EA5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 42% PEG200, 100MM MES PH 6.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.73133 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 91.46267 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 91.46267 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 45.73133 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 39760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 137.19400 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASP A 2 CG OD1 OD2 REMARK 480 HIS A 3 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 3 -40.49 -155.13 REMARK 500 LEU A 23 53.07 38.67 REMARK 500 PHE A 45 -11.84 81.24 REMARK 500 ALA A 60 50.25 -108.56 REMARK 500 SER A 108 74.63 -162.24 REMARK 500 ASN A 131 109.48 -58.37 REMARK 500 LEU A 158 78.93 -119.72 REMARK 500 SER A 200 -119.95 57.64 REMARK 500 GLU A 299 -71.63 -120.21 REMARK 500 THR A 317 -158.87 -158.31 REMARK 500 ASP A 326 66.36 -119.74 REMARK 500 TRP A 378 1.22 -69.96 REMARK 500 ASP A 380 51.66 -155.35 REMARK 500 VAL A 400 -60.86 -125.99 REMARK 500 HIS A 486 -0.30 73.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 442 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1W4L RELATED DB: PDB REMARK 900 COMPLEX OF TCACHE WITH BIS-ACTING GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 1W6R RELATED DB: PDB REMARK 900 COMPLEX OF TCACHE WITH GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 1QTI RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE (E.C.3.1.1.7) COMPLEXED WITH GALANTHAMINE REMARK 900 RELATED ID: 1W76 RELATED DB: PDB REMARK 900 ORTHORHOMBIC FORM OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE (ACHE) REMARK 900 COMPLEXED WITH BIS-ACTING GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 1DX6 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE WITH (-)-GALANTHAMINE AT 2.3A REMARK 900 RESOLUTION REMARK 900 RELATED ID: 3I6Z RELATED DB: PDB REMARK 900 3D STRUCTURE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED REMARK 900 WITH N-SACCHARINOHEXYL-GALANTHAMINE DBREF 3I6M A 2 535 UNP P04058 ACES_TORCA 23 556 SEQRES 1 A 534 ASP HIS SER GLU LEU LEU VAL ASN THR LYS SER GLY LYS SEQRES 2 A 534 VAL MET GLY THR ARG VAL PRO VAL LEU SER SER HIS ILE SEQRES 3 A 534 SER ALA PHE LEU GLY ILE PRO PHE ALA GLU PRO PRO VAL SEQRES 4 A 534 GLY ASN MET ARG PHE ARG ARG PRO GLU PRO LYS LYS PRO SEQRES 5 A 534 TRP SER GLY VAL TRP ASN ALA SER THR TYR PRO ASN ASN SEQRES 6 A 534 CYS GLN GLN TYR VAL ASP GLU GLN PHE PRO GLY PHE SER SEQRES 7 A 534 GLY SER GLU MET TRP ASN PRO ASN ARG GLU MET SER GLU SEQRES 8 A 534 ASP CYS LEU TYR LEU ASN ILE TRP VAL PRO SER PRO ARG SEQRES 9 A 534 PRO LYS SER THR THR VAL MET VAL TRP ILE TYR GLY GLY SEQRES 10 A 534 GLY PHE TYR SER GLY SER SER THR LEU ASP VAL TYR ASN SEQRES 11 A 534 GLY LYS TYR LEU ALA TYR THR GLU GLU VAL VAL LEU VAL SEQRES 12 A 534 SER LEU SER TYR ARG VAL GLY ALA PHE GLY PHE LEU ALA SEQRES 13 A 534 LEU HIS GLY SER GLN GLU ALA PRO GLY ASN VAL GLY LEU SEQRES 14 A 534 LEU ASP GLN ARG MET ALA LEU GLN TRP VAL HIS ASP ASN SEQRES 15 A 534 ILE GLN PHE PHE GLY GLY ASP PRO LYS THR VAL THR ILE SEQRES 16 A 534 PHE GLY GLU SER ALA GLY GLY ALA SER VAL GLY MET HIS SEQRES 17 A 534 ILE LEU SER PRO GLY SER ARG ASP LEU PHE ARG ARG ALA SEQRES 18 A 534 ILE LEU GLN SER GLY SER PRO ASN CYS PRO TRP ALA SER SEQRES 19 A 534 VAL SER VAL ALA GLU GLY ARG ARG ARG ALA VAL GLU LEU SEQRES 20 A 534 GLY ARG ASN LEU ASN CYS ASN LEU ASN SER ASP GLU GLU SEQRES 21 A 534 LEU ILE HIS CYS LEU ARG GLU LYS LYS PRO GLN GLU LEU SEQRES 22 A 534 ILE ASP VAL GLU TRP ASN VAL LEU PRO PHE ASP SER ILE SEQRES 23 A 534 PHE ARG PHE SER PHE VAL PRO VAL ILE ASP GLY GLU PHE SEQRES 24 A 534 PHE PRO THR SER LEU GLU SER MET LEU ASN SER GLY ASN SEQRES 25 A 534 PHE LYS LYS THR GLN ILE LEU LEU GLY VAL ASN LYS ASP SEQRES 26 A 534 GLU GLY SER PHE PHE LEU LEU TYR GLY ALA PRO GLY PHE SEQRES 27 A 534 SER LYS ASP SER GLU SER LYS ILE SER ARG GLU ASP PHE SEQRES 28 A 534 MET SER GLY VAL LYS LEU SER VAL PRO HIS ALA ASN ASP SEQRES 29 A 534 LEU GLY LEU ASP ALA VAL THR LEU GLN TYR THR ASP TRP SEQRES 30 A 534 MET ASP ASP ASN ASN GLY ILE LYS ASN ARG ASP GLY LEU SEQRES 31 A 534 ASP ASP ILE VAL GLY ASP HIS ASN VAL ILE CYS PRO LEU SEQRES 32 A 534 MET HIS PHE VAL ASN LYS TYR THR LYS PHE GLY ASN GLY SEQRES 33 A 534 THR TYR LEU TYR PHE PHE ASN HIS ARG ALA SER ASN LEU SEQRES 34 A 534 VAL TRP PRO GLU TRP MET GLY VAL ILE HIS GLY TYR GLU SEQRES 35 A 534 ILE GLU PHE VAL PHE GLY LEU PRO LEU VAL LYS GLU LEU SEQRES 36 A 534 ASN TYR THR ALA GLU GLU GLU ALA LEU SER ARG ARG ILE SEQRES 37 A 534 MET HIS TYR TRP ALA THR PHE ALA LYS THR GLY ASN PRO SEQRES 38 A 534 ASN GLU PRO HIS SER GLN GLU SER LYS TRP PRO LEU PHE SEQRES 39 A 534 THR THR LYS GLU GLN LYS PHE ILE ASP LEU ASN THR GLU SEQRES 40 A 534 PRO MET LYS VAL HIS GLN ARG LEU ARG VAL GLN MET CYS SEQRES 41 A 534 VAL PHE TRP ASN GLN PHE LEU PRO LYS LEU LEU ASN ALA SEQRES 42 A 534 THR MODRES 3I6M ASN A 59 ASN GLYCOSYLATION SITE MODRES 3I6M ASN A 416 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET NAG A 536 14 HET G3X A 1 29 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM G3X (4AS,6R,8AS)-3-METHOXY-11-(3-PIPERIDIN-1-YLPROPYL)-5,6, HETNAM 2 G3X 9,10,11,12-HEXAHYDRO-4AH-[1]BENZOFURO[3A,3,2- HETNAM 3 G3X EF][2]BENZAZEPIN-6-OL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN G3X (4AS,6R,8AS)-4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-[3- HETSYN 2 G3X (1-PIPERIDINYL)PROPYL]-6H-BENZOFURO[3A,3,2- HETSYN 3 G3X EF][2]BENZAZEPIN-6-OL FORMUL 2 NAG 3(C8 H15 N O6) FORMUL 4 G3X C24 H34 N2 O3 FORMUL 5 HOH *398(H2 O) HELIX 1 1 VAL A 40 ARG A 44 5 5 HELIX 2 2 PHE A 78 MET A 83 1 6 HELIX 3 3 LEU A 127 ASN A 131 5 5 HELIX 4 4 GLY A 132 GLU A 140 1 9 HELIX 5 5 VAL A 150 LEU A 156 1 7 HELIX 6 6 ASN A 167 ILE A 184 1 18 HELIX 7 7 GLN A 185 PHE A 187 5 3 HELIX 8 8 SER A 200 SER A 212 1 13 HELIX 9 9 SER A 215 PHE A 219 5 5 HELIX 10 10 SER A 237 LEU A 252 1 16 HELIX 11 11 SER A 258 LYS A 269 1 12 HELIX 12 12 LYS A 270 GLU A 278 1 9 HELIX 13 13 TRP A 279 LEU A 282 5 4 HELIX 14 14 SER A 304 GLY A 312 1 9 HELIX 15 15 GLY A 328 ALA A 336 1 9 HELIX 16 16 SER A 348 VAL A 360 1 13 HELIX 17 17 ASN A 364 THR A 376 1 13 HELIX 18 18 ASN A 383 VAL A 400 1 18 HELIX 19 19 VAL A 400 GLY A 415 1 16 HELIX 20 20 PRO A 433 GLY A 437 5 5 HELIX 21 21 GLU A 443 PHE A 448 1 6 HELIX 22 22 GLY A 449 ASN A 457 5 9 HELIX 23 23 THR A 459 GLY A 480 1 22 HELIX 24 24 ARG A 517 GLN A 526 1 10 HELIX 25 25 GLN A 526 THR A 535 1 10 SHEET 1 A 3 LEU A 7 THR A 10 0 SHEET 2 A 3 GLY A 13 MET A 16 -1 O VAL A 15 N VAL A 8 SHEET 3 A 3 VAL A 57 ASN A 59 1 O TRP A 58 N MET A 16 SHEET 1 B11 THR A 18 VAL A 22 0 SHEET 2 B11 SER A 25 PRO A 34 -1 O ILE A 27 N VAL A 20 SHEET 3 B11 TYR A 96 VAL A 101 -1 O ILE A 99 N PHE A 30 SHEET 4 B11 VAL A 142 SER A 145 -1 O LEU A 143 N TRP A 100 SHEET 5 B11 THR A 109 ILE A 115 1 N TRP A 114 O VAL A 144 SHEET 6 B11 GLY A 189 GLU A 199 1 O THR A 195 N VAL A 113 SHEET 7 B11 ARG A 221 GLN A 225 1 O GLN A 225 N GLY A 198 SHEET 8 B11 GLN A 318 ASN A 324 1 O LEU A 320 N LEU A 224 SHEET 9 B11 GLY A 417 PHE A 423 1 O PHE A 423 N VAL A 323 SHEET 10 B11 LYS A 501 LEU A 505 1 O LEU A 505 N PHE A 422 SHEET 11 B11 VAL A 512 GLN A 514 -1 O HIS A 513 N PHE A 502 SSBOND 1 CYS A 67 CYS A 94 1555 1555 2.06 SSBOND 2 CYS A 254 CYS A 265 1555 1555 2.05 SSBOND 3 CYS A 402 CYS A 521 1555 1555 2.04 LINK ND2 ASN A 59 C1 NAG A 536 1555 1555 1.46 LINK ND2 ASN A 416 C1 NAG B 1 1555 1555 1.45 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.40 CISPEP 1 SER A 103 PRO A 104 0 0.31 CRYST1 112.194 112.194 137.194 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008913 0.005146 0.000000 0.00000 SCALE2 0.000000 0.010292 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007289 0.00000